Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis

被引:131
作者
Theede, Klaus [1 ]
Holck, Susanne [2 ]
Ibsen, Per [2 ]
Ladelund, Steen [3 ]
Nordgaard-Lassen, Inge [1 ]
Nielsen, Anette Mertz [1 ]
机构
[1] Copenhagen Univ Hosp, Div Med, Gastrounit, Hvidovre, Denmark
[2] Copenhagen Univ Hosp, Dept Pathol, Hvidovre, Denmark
[3] Copenhagen Univ Hosp, Dept Stat, Clin Res Ctr, Hvidovre, Denmark
关键词
Inflammatory Bowel Disease; IBD; Outcome; Marker; C-REACTIVE PROTEIN; BOWEL-DISEASE; ACTIVITY INDEX; MARKER; REMISSION; SEVERITY; THERAPY; RELAPSE; SCORE;
D O I
10.1016/j.cgh.2015.05.038
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: In patients with ulcerative colitis (UC), mucosal healing is an important goal of treatment. However, mucosal healing is difficult to determine on the basis of clinical evaluation alone, and endoscopy is uncomfortable and can cause complications. Fecal calprotectin (FC) is a marker of inflammation, and its levels have been associated with disease activity. We investigated the association between level of FC and mucosal healing and clinical disease activity in patients with UC. METHODS: We performed an observational cross-sectional study of 120 patients with active or inactive UC who underwent sigmoidoscopy at Copenhagen University Hospital Hvidovre from September 2012 through 2014. Endoscopic inflammation was evaluated by using the Mayo Endoscopic Score (MES) and Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and histologic inflammatory activity by a slightly modified Harpaz Index, which measures acute inflammation. The Partial Mayo Score was used to measure the clinical disease activity. RESULTS: A cutoff level of FC of 192 mg/kg identified patients with endoscopic evidence of mucosal healing, which was based on the MES and UCEIS, with positive predictive values of 0.71 and 0.65, respectively; negative predictive values were 0.90 and 0.93, respectively. A cutoff level of 171 mg/kg identified patients with histologic evidence of mucosal healing, with positive predictive value of 0.75 and negative predictive value of 0.90. Levels of FC increased significantly with increases in endoscopic and histologic disease activity. There was high concordance between MES and UCEIS as well as between MES or UCEIS and histologic inflammatory activity. The histologic activity index had an interobserver variation of 4.35%. CONCLUSIONS: Level of FC identifies patients with UC who have endoscopic and histologic features of mucosal healing and correlates with endoscopic and histologic inflammatory activity. The UCEIS seems to be as accurate as the MES in identifying patients with mucosal healing and as easy to use. The histologic activity index had a high concordance with recognized endoscopic score systems.
引用
收藏
页码:1929 / +
页数:9
相关论文
共 32 条
  • [1] Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis
    Ardizzone, Sandro
    Cassinotti, Andrea
    Duca, Piergiorgio
    Mazzali, Cristina
    Penati, Chiara
    Manes, Gianpiero
    Marmo, Riccardo
    Massari, Alessandro
    Molteni, Paola
    Maconi, Giovanni
    Porro, Gabriele Bianchi
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (06) : 483 - U117
  • [2] Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation
    Baars, Judith E.
    Nuij, Veerle J. A. A.
    Oldenburg, Bas
    Kuipers, Ernst J.
    van der Woude, Christien J.
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (09) : 1634 - 1640
  • [3] Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing
    Bessissow, Talat
    Lemmens, Bart
    Ferrante, Marc
    Bisschops, Raf
    Van Steen, Kristel
    Geboes, Karel
    Van Assche, Gert
    Vermeire, Severine
    Rutgeerts, Paul
    De Hertogh, Gert
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (11) : 1684 - 1692
  • [4] Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
    Costa, F
    Mumolo, MG
    Ceccarelli, L
    Bellini, M
    Romano, MR
    Sterpi, C
    Ricchiuti, A
    Marchi, S
    Bottai, M
    [J]. GUT, 2005, 54 (03) : 364 - 368
  • [5] Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
    D'Haens, Geert
    Ferrante, Marc
    Vermeire, Severine
    Baert, Filip
    Noman, Maja
    Moortgat, Liesbeth
    Geens, Patricia
    Iwens, Doreen
    Aerden, Isolde
    Van Assche, Gert
    Van Olmen, Gust
    Rutgeerts, Paul
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2218 - 2224
  • [6] Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis
    De Vos, M.
    Dewit, O.
    D'Haens, G.
    Baert, F.
    Fontaine, F.
    Vermeire, S.
    Franchimont, D.
    Moreels, T.
    Staessen, D.
    Terriere, L.
    Vander Cruyssen, B.
    Louis, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2012, 6 (05) : 557 - 562
  • [7] Fiel MI, 2003, LAB INVEST, V83, p118A
  • [8] Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
    Froslie, Kathrine Frey
    Jahnsen, Jorgen
    Moum, Bjorn A.
    Vatn, Morten H.
    [J]. GASTROENTEROLOGY, 2007, 133 (02) : 412 - 422
  • [9] A reproducible grading scale for histological assessment of inflammation in ulcerative colitis
    Geboes, K
    Riddell, R
    Öst, A
    Jensfelt, B
    Persson, T
    Löfberg, R
    [J]. GUT, 2000, 47 (03) : 404 - 409
  • [10] Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse
    Gisbert, Javier P.
    Bermejo, Fernando
    Perez-Calle, Jose-Lazaro
    Taxonera, Carlos
    Vera, Isabel
    McNicholl, Adrian G.
    Algaba, Alicia
    Lopez, Pilar
    Lopez-Palacios, Natalia
    Calvo, Marta
    Gonzalez-Lama, Yago
    Carneros, Jose-Antonio
    Velasco, Marta
    Mate, Jose
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (08) : 1190 - 1198